Prognostic Stage III Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Exemestane (DB00990)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT03554044T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerTreatment